British Teen Isabelle Holdaway Receives First Genetically Modified Phage Therapy for Drug-Resistant Infection May 8, 2019

British 17-year-old Isabelle Holdaway is reported to be the first patient ever to receive a genetically modified phage therapy to treat a drug-resistant infection.

British 17-year-old Isabelle Holdaway is reported to be the first patient ever to receive a genetically modified phage therapy to treat a drug-resistant infection.

Date: May 8, 2019

Read more on Wikipedia →

📅 Other events on May 8

📅 Events on this day in 2019

📅 On This Day (Today)

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *